LAW GROUP has launched a nationwide class action against manufacturers of Xarelto (rivaroxaban), marketed and sold in Canada by Bayer, Janssen and Johnson & Johnson and suffered bleeding after taking the anticoagulant drug.

- Xarelto is approved to treat deep vein thrombosis and pulmonary embolism, and is sometimes prescribed following the replacement of the hip or knee;

- Xarelto has been linked to complications including intestinal bleeding, rectal bleeding, blood clots, brain hemorrhage, pulmonary embolism and deep vein thrombosis;

- Unlike warfarin, there is no known antidote to stop bleeding caused by this drug.

Xarelto manufacturers and traders still fail to warn consumers, health professionals and the public:

a. The serious and significant risk of serious and irreversible hemorrhagic complications;

b. that in the event of complications causing bleeding, there is no antidote to reverse; and

c. That people taking Xarelto should closely monitor their blood and frequently.
 

This Class Action Identifies Those Affected As:

All persons residing in Canada who took and / or purchased the RIVAROXABAN drug (sold under the brand name Xarelto) since 2008, and their successors, assigns, family members and people dependents, or any other group to be determined by the Court.

The "Food and Drug Administration" in the United States has received 680 reports of adverse events among Xarelto users in 2013, according to Digital Journal. Meanwhile, in Germany, Der Spiegel magazine reported that between January 2012 and September 2013, Xarelto has been linked to 130 deaths and 1700 cases serious complications. According to press reports, Xarelto may be responsible for 1,400 deaths.

The most serious problem associated with Xarelto and similar drugs is fatal hemorrhage. When a patient taking this drug starts to bleed, if only as a minor injury (including a bump on the head), there is virtually no way to stop it.

The reason for this resides in the mechanism of drug action. Blood clotting resulting from the action of vitamin K (found naturally in leafy vegetables and cruciferous vegetables like cabbage) to produce thrombin clotting agent. Warfarin deactivates vitamin K, so any severe bleeding can be stopped with high doses of this vitamin. Xarelto prevents the production of vitamin K in total. Therefore, once a patient starts bleeding, there is virtually no way to stop it.

Other potentially serious side effects include diarrhea, arrhythmia (irregular heartbeat), tachycardia (rapid heartbeat) and large, sudden changes in blood pressure. While not always life-threatening, the symptoms can be severe if the patient does not receive prompt medical treatment.

If you or a family member have used the drug Xarelto and then have been injured, and want to receive more information on the potential compensation or to be kept informed of the progress of this lawsuit or any compensation arising from this class action in United States.
 

External Links:

Tumblr

Wix

Sitey

Jigsy